Historical data shows that a consistent $500 monthly investment into Calidi Biotherapeutics, Inc. (CLDI) starting in 2020 would have turned a total investment of $38K into $2K today. This represents a total return of -95.2% over the 6-year period, compounding through dividend reinvestment and market growth.
The Impact of Dividend Reinvestment (DRIP)
Calidi Biotherapeutics, Inc. pays a dividend (currently yielding ~1.00%). By utilizing a Dividend Reinvestment Plan (DRIP), generated dividends automatically purchase fractional shares. Over this 6-year period, regular dividend payments totaled $0. Reinvesting these dividends continuously compounded your returns, accelerating the portfolio's growth far beyond simple price appreciation.
CLDI vs. S&P 500 (SPY) Benchmark
When comparing this dollar cost averaging strategy against a broad market index,CLDI underperformed the S&P 500 ETF (SPY). The same $500 monthly contributions into SPY would have grown to $57K, compared to CLDI's $2K.